Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
2,291.25
81.5 (3.69%)
BSENSE

Oct 09

BSE+NSE Vol: 4.54 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 780863,
    "name": "Glenmark Pharma",
    "stock_name": "Glenmark Pharma",
    "full_name": "Glenmark Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/glenmark-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,291.25",
    "chg": 81.5,
    "chgp": "3.69%",
    "dir": 1,
    "prev_price": "2,209.75",
    "mcapval": "64,664.73 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532296,
    "symbol": "GLENMARK",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE935A01035",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "4.54 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/glenmark-pharma-780863-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glenmark launches new pump packs for OTC adapalene gel in US market",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-10-06 09:41:52",
        "description": "Glenmark launches new pump packs for OTC adapalene gel in US market  Business Standard..."
      },
      {
        "title": "Glenmark Pharma gets EIR for Goa facility from US FDA",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-23 15:16:51",
        "description": "Glenmark Pharma gets EIR for Goa facility from US FDA  Business Standard..."
      },
      {
        "title": "Glenmark Pharma stock reacts as Goa facility gets VAI status post USFDA inspection",
        "link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPN25uNHZMU2lhMjBmWGlfbGN5WDA4c3lnQkd6bER6a3I5MGpnMVU1VEE0OGk2MURMZDJTeWd2WEROU01Gd3FFQ19JY3ZKUkc5WVp5anRZTVQtbmZUTVJHdThhT0RBbzY5UlZvaVZHSE1nWWtrMlFPazRJMFFacTI2Y0RlS21aaFdsQS0ybmpPZldnWlgtYXBvbUZwZ0w5LW85WVNpQk5hU3hpQUYwZGRJTnlUcElydGRwNmJRdE80Q2tqZk1XNlhQNE1Zd0pNUkVKTzlpdmtBdllRZzcyUkhKbW5qQW5BVjNCcW1hdEp4NF_SAfYBQVVfeXFMT09oc2pXVzEwNTNQVjhzelcwYnI5QWpicXFtX3F6Z3BHT0ZackJtQTJGdWtUazNnSlJPWDlsbkE0czRoM05mbmw0N1MxOWhtVFNWcTd5U2hEQzVyZ1hQNExEd1IyXzdFbzBCaHNuZWJLZnZ3SWRFQmY0V1E3SUxRakppZUZiY0Y2QzdRdDJNQjg3UXdLN3cwNUh4RnczXzlKbTNpR0tzUmhvUDRDNkgwNlhKUHRsZ1JhSWJSOG9DTFFmaUp1c0dHZmN6Xy1fYXZFdTRZcGFPT084QWhGY1p6RlhyaFdLY3hxWWNoaEVhclpmVm9KM3J3?oc=5",
        "imagepath": "",
        "date": "2026-09-23 09:30:45",
        "description": "Glenmark Pharma stock reacts as Goa facility gets VAI status post USFDA inspection  Business Today..."
      },
      {
        "title": "Glenmark Pharmaceuticals Ltd spurts 0.5%, gains for fifth straight session",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-22 13:32:10",
        "description": "Glenmark Pharmaceuticals Ltd spurts 0.5%, gains for fifth straight session  Business Standard..."
      }
    ],
    "total": 4,
    "sid": "780863",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/glenmark-pharmaceuticals-780863"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "06-Oct-2026",
      "details": "Glenmark Therapeutics Inc. USA launches Pump Packs for Adapalene Gel USP 0.1% (OTC)",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "28-Sep-2026",
      "details": "Intimation for closure of trading window for second quarter of FY 2026-27",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "23-Sep-2026",
      "details": "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIS) from U.S. FDA for its Goa facility with VAI classification",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has declared <strong>250%</strong> dividend, ex-date: 31 Aug 26",
          "dt": "2026-08-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has announced <strong>1:2</strong> stock split, ex-date: 10 Sep 07",
          "dt": "2007-09-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

06-Oct-2026 | Source : BSE

Glenmark Therapeutics Inc. USA launches Pump Packs for Adapalene Gel USP 0.1% (OTC)

Closure of Trading Window

28-Sep-2026 | Source : BSE

Intimation for closure of trading window for second quarter of FY 2026-27

Announcement under Regulation 30 (LODR)-Press Release / Media Release

23-Sep-2026 | Source : BSE

Glenmark Pharmaceuticals receives Establishment Inspection Report (EIS) from U.S. FDA for its Goa facility with VAI classification

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Glenmark Pharmaceuticals Ltd. has declared 250% dividend, ex-date: 31 Aug 26

stock-summary
SPLITS

Glenmark Pharmaceuticals Ltd. has announced 1:2 stock split, ex-date: 10 Sep 07

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available